CMMBVSGLMD• 6 Months (Normalized)
CMMB vs GLMD (Chemomab Therapeutics Ltd. vs Galmed Pharmaceuticals Ltd.)
Showing Closing Date Range from Apr 3 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
+0.6%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
GLMD Performance $3.55
+581.38%
Galmed Pharmaceuticals Ltd.
Normalized Baseline0.00%
Alpha Spread Margin GLMD LEADS
-580.78 pts
GLMD outperforming by 580.78 percentage points
CMMBGLMD
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB GLMD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | CMMB Price | CMMB Gain (%) | GLMD Price | GLMD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | +0.60% | $3.55 | +581.38% | -580.78% |
| Sep 28, 2026 | $1.64 | -1.20% | $3.63 | +596.74% | -597.94% |
| Sep 25, 2026 | $2.16 | +30.12% | $3.63 | +596.74% | -566.62% |
| Sep 24, 2026 | $2.20 | +32.53% | $3.62 | +594.82% | -562.29% |
| Sep 23, 2026 | $2.28 | +37.35% | $3.62 | +594.82% | -557.47% |
| Sep 22, 2026 | $2.51 | +51.20% | $- | - | |
| Sep 21, 2026 | $2.48 | +49.40% | $3.50 | +571.79% | -522.39% |
| Sep 18, 2026 | $2.61 | +57.23% | $3.40 | +552.59% | -495.36% |
| Sep 17, 2026 | $2.80 | +68.67% | $3.48 | +567.95% | -499.28% |
| Sep 16, 2026 | $2.65 | +59.64% | $3.41 | +554.51% | -494.87% |
| Sep 15, 2026 | $2.47 | +48.80% | $3.63 | +595.78% | -546.98% |
| Sep 14, 2026 | $2.45 | +47.59% | $3.82 | +633.21% | -585.62% |
| Sep 11, 2026 | $2.58 | +55.42% | $3.84 | +637.04% | -581.62% |
| Sep 10, 2026 | $2.60 | +56.63% | $4.03 | +673.51% | -616.88% |
| Sep 09, 2026 | $2.69 | +62.05% | $4.63 | +788.68% | -726.63% |
Page 1 of 9